Understanding how T cell receptors work in the immune system
NMR Methods to decipher the structural and dynamics aspects of TCR mechanobiology
This study is looking at how T cells, which are important for fighting diseases, recognize and respond to threats in the body by examining the tiny interactions between their receptors and the molecules they bind to, using special techniques to understand how physical forces affect their activity.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10877948 on NIH RePORTER |
What this research studies
This research investigates the dynamic interactions between T cell receptors (TCR) and their peptide-MHC ligands, which are crucial for T cell function in recognizing and responding to diseases. Using advanced NMR techniques, the study aims to uncover how mechanical forces influence TCR signaling and the resulting immune responses. By focusing on large protein complexes that are difficult to study with traditional methods, the research seeks to provide insights into the molecular mechanisms that drive T cell activation and function.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve T cell dysfunction or require enhanced immune responses, such as cancer patients or those with autoimmune diseases.
Not a fit: Patients with conditions unrelated to T cell function or those who do not require immune modulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for enhancing immune responses against diseases such as cancer and infections.
How similar studies have performed: Previous research has shown promise in understanding T cell mechanics, but this approach using NMR for large protein complexes is relatively novel.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Wagner, Gerhard — Dana-Farber Cancer Inst
- Study coordinator: Wagner, Gerhard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.